Elicio Therapeutics (ELTX) Other Working Capital Changes (2020 - 2025)

Elicio Therapeutics (ELTX) has reported Other Working Capital Changes for 7 consecutive years, with $753000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Working Capital Changes rose 164.25% year-over-year to $753000.0; the trailing twelve-month figure through Jun 2026 stood at $1.5 million (up 183.06% YoY), and the FY2025 full-year result was -$1.1 million, down 26.13% from the prior year.
• Other Working Capital Changes advanced to $753000.0 in Q2 2026 per ELTX's latest filing, from $504000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $2.2 million in Q3 2022 and bottomed at -$25.1 million in Q4 2021.
• Historically, Other Working Capital Changes has averaged -$1.5 million across 5 years, with a median of -$498000.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes jumped 1288.24% in 2022, then sank 299.66% in 2025.
• Over 5 years, Other Working Capital Changes stood at $472000.0 in 2022, then slumped by 150.21% to -$237000.0 in 2023, then advanced by 11.81% to -$209000.0 in 2024, then surged by 49.28% to -$106000.0 in 2025, then soared by 810.38% to $753000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $753000.0, $504000.0, and -$106000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.